Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

(2016) Marlous Arjaans et al.   Oncotarget

Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies

(2015) Thomas K Chung et al.   CANCER BIOLOGY & THERAPY

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway

(2014) Alexander Gross et al.   Targeted Oncology

Bevacizumab-Induced Vessel Normalization Hampers Tumor Uptake of Antibodies--Response

(2013) M. Arjaans et al.   CANCER RESEARCH

Activities of multiple cancer-related pathways are associated withBRAFmutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells

(2013) Dingxie Liu et al.   CELL CYCLE

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

(2013) Rakesh K. Jain   JOURNAL OF CLINICAL ONCOLOGY

Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma

(2013) Kristine E. Day et al.   LARYNGOSCOPE

Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma

(2013) Kristine E. Day et al.   MOLECULAR IMAGING AND BIOLOGY

Use of Panitumumab-IRDye800 to Image Microscopic Head and Neck Cancer in an Orthotopic Surgical Model

(2012) C. Hope Heath et al.   ANNALS OF SURGICAL ONCOLOGY

Cancers with increasing incidence trends in the United States: 1999 through 2008

(2012) Edgar P. Simard et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies

(2012) Justin N. Bottsford-Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiangiogenic therapy—evolving view based on clinical trial results

(2012) Gordon C. Jayson et al.   Nature Reviews Clinical Oncology

Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models

(2011) Kentaro Yamanaka et al.   CLINICAL CANCER RESEARCH

EGFR expression in advanced head and neck cutaneous squamous cell carcinoma

(2011) Larissa Sweeny et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis

(2011) Stijn Keereweer et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

EGFR in melanoma: clinical significance and potential therapeutic target

(2011) Barbara Boone et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma

(2011) Qingjun Liu et al.   Molecular Cancer

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

(2011) Peter Carmeliet et al.   NATURE REVIEWS DRUG DISCOVERY

Current and Future Clinical Applications for Optical Imaging of Cancer: From Intraoperative Surgical Guidance to Cancer Screening

(2011) Costas G. Hadjipanayis et al.   SEMINARS IN ONCOLOGY

Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

(2010) Milton V. Marshall et al.   MOLECULAR IMAGING AND BIOLOGY

Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival

(2010) Q. T. Nguyen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

(2009) Christopher G. Willett et al.   JOURNAL OF CLINICAL ONCOLOGY

Delineating melanoma using multimodal polarized light imaging

(2009) Zeina Tannous et al.   LASERS IN SURGERY AND MEDICINE

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE

Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma

(2008) M. González-Cao et al.   ONCOLOGY

Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma

(2007) Sydney Ch'ng et al.   HUMAN PATHOLOGY